{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:52:15Z","timestamp":1785891135500,"version":"3.56.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073096"],"award-info":[{"award-number":["82073096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303362"],"award-info":[{"award-number":["82303362"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016104","name":"Key Project of Research and Development Plan of Hunan Province","doi-asserted-by":"publisher","award":["2024DK2006"],"award-info":[{"award-number":["2024DK2006"]}],"id":[{"id":"10.13039\/100016104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","award":["20231708"],"award-info":[{"award-number":["20231708"]}],"id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ60497"],"award-info":[{"award-number":["2025JJ60497"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2026JJ80660"],"award-info":[{"award-number":["2026JJ80660"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ30039"],"award-info":[{"award-number":["2025JJ30039"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218667","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:09:31Z","timestamp":1781222971000},"page":"218667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma"],"prefix":"10.1016","volume":"657","author":[{"given":"Haijuan","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218667_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217873","article-title":"Isocucurbitacin B inhibits gliomas through the promotion of anoikis by targeting caveolin 1","volume":"629","author":"Han","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218667_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218278","article-title":"FIG4 downregulation-arrested autophagy-lysosomal degradation of IL-18 drives lipid-associated macrophage polarization and immunotherapy resistance in triple-negative breast cancer","volume":"641","author":"Xia","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218667_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218667_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","article-title":"Primary brain tumours in adults","volume":"392","author":"Lapointe","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218667_bib6","article-title":"An MRI radiogenomic signature to characterize the transcriptional heterogeneity associated with prognosis and biological functions in glioblastoma","author":"Zhang","year":"2025","journal-title":"Front Biosci (Landmark Ed), Singapore"},{"key":"10.1016\/j.canlet.2026.218667_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218667_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22973","article-title":"CN-3 increases TMZ sensitivity and induces ROS-dependent apoptosis and autophagy in TMZ-Resistance glioblastoma","volume":"36","author":"Xue","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.canlet.2026.218667_bib9","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.apsb.2022.06.004","article-title":"Autophagy and beyond: unraveling the complexity of UNC-51-like kinase 1 (ULK1) from biological functions to therapeutic implications","volume":"12","author":"Zou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2026.218667_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41419-020-02988-8","article-title":"Wnt\/beta-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma","volume":"11","author":"Yun","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218667_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells13161332","article-title":"Importance of autophagy regulation in glioblastoma with temozolomide resistance","volume":"13","author":"Hwang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218667_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1297506","article-title":"Biology of endophilin and it's role in disease","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218667_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13046-022-02429-8","article-title":"SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma","volume":"41","author":"Chien","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218667_bib14","article-title":"ADAR1 promotes the progression and temozolomide resistance of glioma through p62-Mediated selective autophagy","volume":"31","author":"Zhang","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.canlet.2026.218667_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1397863","article-title":"Revisiting the potential of regulated cell death in glioma treatment: a focus on autophagy-dependent cell death, anoikis, ferroptosis, cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk between them","volume":"14","author":"Luo","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/cns.13821","article-title":"Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma","volume":"28","author":"Yuan","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.canlet.2026.218667_bib17","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.7150\/thno.41450","article-title":"Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells","volume":"10","author":"Lopez-Valero","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2026.218667_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4161\/auto.23323","article-title":"The ULK1 complex: sensing nutrient signals for autophagy activation","volume":"9","author":"Wong","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218667_bib18","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1016\/j.molcel.2024.10.046","article-title":"The phosphatase PP1 sustains global transcription by promoting RNA polymerase II pause release","volume":"84","author":"Wang","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib19","doi-asserted-by":"crossref","first-page":"9822","DOI":"10.1038\/s41467-024-54256-4","article-title":"PPP1R2 stimulates protein phosphatase-1 through stabilisation of dynamic subunit interactions","volume":"15","author":"Lemaire","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218667_bib20","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.drudis.2021.08.001","article-title":"Modulation of serine\/threonine-protein phosphatase 1 (PP1) complexes: a promising approach in cancer treatment","volume":"26","author":"Matos","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.canlet.2026.218667_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","article-title":"Serine\/threonine phosphatases: mechanism through structure","volume":"139","author":"Shi","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2415383121","article-title":"A protein phosphatase 1 specific phosphatase targeting peptide (PhosTAP) to identify the PP1 phosphatome","volume":"121","author":"Choy","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218667_bib23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tibs.2010.03.002","article-title":"The extended PP1 toolkit: designed to create specificity","volume":"35","author":"Bollen","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218667_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-08132-2","article-title":"Postsynaptic competition between calcineurin and PKA regulates mammalian sleep-wake cycles","volume":"636","author":"Wang","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218667_bib25","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2026.218667_bib26","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41418-023-01210-4","article-title":"Lysine methylation of PPP1CA by the methyltransferase SUV39H2 disrupts TFEB-dependent autophagy and promotes intervertebral disc degeneration","volume":"30","author":"Liang","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218667_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-025-03320-y","article-title":"Protein phosphatase 1 regulatory subunit 15 A (PPP1R15A) promoted the progression of gastric cancer by activating cell autophagy under energy stress","volume":"44","author":"Cui","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218667_bib28","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1080\/15548627.2016.1203483","article-title":"Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy","volume":"12","author":"Wang","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218667_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218667_bib30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-019-0512-3","article-title":"ELFN2 is a postsynaptic cell adhesion molecule with essential roles in controlling group III mGluRs in the brain and neuropsychiatric behavior","volume":"24","author":"Dunn","year":"2019","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.canlet.2026.218667_bib31","doi-asserted-by":"crossref","first-page":"23914","DOI":"10.1073\/pnas.2009940117","article-title":"Interplay between cell-adhesion molecules governs synaptic wiring of cone photoreceptors","volume":"117","author":"Cao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218667_bib32","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1523\/JNEUROSCI.2276-18.2019","article-title":"Elfn1-Induced constitutive activation of mGluR7 determines frequency-dependent recruitment of somatostatin interneurons","volume":"39","author":"Stachniak","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.canlet.2026.218667_bib33","article-title":"Trans-Synaptic regulation of metabotropic glutamate receptors by Elfn proteins in health and disease","volume":"15","author":"Matsunaga","year":"2021","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.canlet.2026.218667_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chembiol.2009.02.012","article-title":"Docking motif-guided mapping of the interactome of protein phosphatase-1","volume":"16","author":"Hendrickx","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.canlet.2026.218667_bib35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-024-01940-0","article-title":"A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway","volume":"23","author":"Huang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218667_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111497","article-title":"LRRC62 attenuates toll-like receptor signaling by deubiquitinating TAK1 via CYLD","volume":"383","author":"Zhang","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2026.218667_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib38","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ccr.2014.06.005","article-title":"Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma","volume":"26","author":"Ozawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib39","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.ymthe.2018.06.019","article-title":"LINC00470 coordinates the epigenetic regulation of ELFN2 to distract GBM cell autophagy","volume":"26","author":"Liu","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2026.218667_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature09609","article-title":"Integrative genomics identifies LMO1 as a neuroblastoma oncogene","author":"Wang","year":"2011","journal-title":"Nature, England"},{"key":"10.1016\/j.canlet.2026.218667_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biosystems.2013.07.003","article-title":"Alternative splicing of mutually exclusive exons--a review","volume":"114","author":"Pohl","year":"2013","journal-title":"Biosystems"},{"key":"10.1016\/j.canlet.2026.218667_bib42","first-page":"671","article-title":"Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity","author":"Schmucker","year":"2000","journal-title":"Cell, United States"},{"key":"10.1016\/j.canlet.2026.218667_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41586-021-03662-5","article-title":"Phase separation drives aberrant chromatin looping and cancer development","volume":"595","author":"Ahn","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218667_bib44","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1634\/theoncologist.2017-0572","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors for central nervous system metastases from non-small cell lung cancer","volume":"23","author":"Ahluwalia","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218667_bib45","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1080\/15548627.2023.2242696","article-title":"Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate","volume":"19","author":"Ou","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218667_bib46","article-title":"Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236\/HER2 signaling pathway","volume":"2023","author":"Liu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218667_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216508","article-title":"A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer","volume":"581","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218667_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218667_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","author":"Kim","year":"2011","journal-title":"Nat Cell Biol, England"},{"key":"10.1016\/j.canlet.2026.218667_bib51","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib52","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","article-title":"Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment","volume":"10","author":"Dirkse","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218667_bib53","first-page":"75","article-title":"Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis","volume":"569","author":"Bindra","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.canlet.2026.218667_bib54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218667_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","author":"Li","year":"2020","journal-title":"Mol Cancer, England"},{"key":"10.1016\/j.canlet.2026.218667_bib57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4161\/auto.7.6.15123","article-title":"The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR","volume":"7","author":"Egan","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218667_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12915-024-02075-w","article-title":"The neglected burden of chronic hypoxia on the resistance of glioblastoma multiforme to first-line therapies","author":"Bou-Gharios","year":"2024","journal-title":"BMC Biol, England"},{"key":"10.1016\/j.canlet.2026.218667_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010157","article-title":"Inhibition of carbonic anhydrase 2 overcomes temozolomide resistance in glioblastoma cells","author":"Zhao","year":"2021","journal-title":"Int J Mol Sci, Switzerland"},{"key":"10.1016\/j.canlet.2026.218667_bib60","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2026.218667_bib61","first-page":"vdae014","article-title":"A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma","author":"Driscoll","year":"2024","journal-title":"Neurooncol Adv, England"},{"key":"10.1016\/j.canlet.2026.218667_bib62","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2007.05.036","article-title":"SR proteins function in coupling RNAP II transcription to pre-mRNA splicing","volume":"26","author":"Das","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib63","doi-asserted-by":"crossref","first-page":"21235","DOI":"10.18632\/oncotarget.6908","article-title":"Autophagy-associated immune responses and cancer immunotherapy","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218667_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk7812","article-title":"Antigen-presenting cell activation requires intrinsic and extrinsic STING signaling after the phagocytosis of DNA-damaged cells","volume":"9","author":"Park","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218667_bib65","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1073\/pnas.96.11.6125","article-title":"The SRm160\/300 splicing coactivator is required for exon-enhancer function","author":"Eldridge","year":"1999","journal-title":"Proc Natl Acad Sci U S A, United States"},{"key":"10.1016\/j.canlet.2026.218667_bib66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/iub.2410","article-title":"m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK\/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation","volume":"73","author":"Ma","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2026.218667_bib67","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2017.10.037","article-title":"Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling","volume":"171","author":"Lee","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib68","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.molcel.2023.07.017","article-title":"FAM120A couples SREBP-dependent transcription and splicing of lipogenesis enzymes downstream of mTORC1","volume":"83","author":"Cho","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218667_bib69","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1186\/s12885-022-10062-z","article-title":"An IGF-1R-mTORC1-SRPK2 signaling axis contributes to FASN regulation in breast cancer","volume":"22","author":"McClellan","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2026.218667_bib70","first-page":"761","article-title":"TMBIM6 (transmembrane BAX inhibitor motif containing 6) enhances autophagy through regulation of lysosomal calcium","author":"Kim","year":"2021","journal-title":"Autophagy, United States"},{"key":"10.1016\/j.canlet.2026.218667_bib71","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1038\/emboj.2011.318","article-title":"BAX inhibitor-1 regulates autophagy by controlling the IRE1alpha branch of the unfolded protein response","author":"Castillo","year":"2011","journal-title":"EMBO J, England"},{"key":"10.1016\/j.canlet.2026.218667_bib72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218667_bib73","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","article-title":"Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218667_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218667_bib75","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.tips.2023.02.003","article-title":"Recent advances in targeting autophagy in cancer","volume":"44","author":"Jain","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2026.218667_bib76","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","article-title":"Writers, readers, and erasers RNA modifications and drug resistance in cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218667_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcancer.2019.05.020","article-title":"Epigenetic modifications of autophagy in cancer and cancer therapeutics","volume":"66","author":"Bhol","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2026.218667_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41418-023-01201-5","article-title":"Post-transcriptional dynamics and RNA homeostasis in autophagy and cancer","volume":"32","author":"Kolapalli","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218667_bib79","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1093\/carcin\/bgt247","article-title":"RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation","volume":"34","author":"Shimoni-Sebag","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2026.218667_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108073","article-title":"Distinct autoregulatory roles of ELFN1 intracellular and extracellular domains on membrane trafficking, synaptic localization, and dimerization","volume":"301","author":"Dunn","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218667_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-016-0355-1","article-title":"The D domain of LRRC4 anchors ERK1\/2 in the cytoplasm and competitively inhibits MEK\/ERK activation in glioma cells","volume":"9","author":"Wang","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib82","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1476-4598-13-266","article-title":"Function and mechanism of tumor suppressor gene LRRC4\/NGL-2","volume":"13","author":"Li","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218667_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125590","article-title":"Membrane-bound transcription factor LRRC4 inhibits glioblastoma cell motility","volume":"246","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.canlet.2026.218667_bib84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CM9.0000000000002441","article-title":"Leucine-rich repeats containing 4 protein (LRRC4) in memory, psychoneurosis, and glioblastoma","volume":"136","author":"Deng","year":"2023","journal-title":"Chin. Med. J. (Engl. Ed.)"},{"key":"10.1016\/j.canlet.2026.218667_bib85","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/neuonc\/noab115","article-title":"BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma","volume":"23","author":"Gusyatiner","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib86","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13046-020-01643-6","article-title":"The application of histone deacetylases inhibitors in glioblastoma","volume":"39","author":"Chen","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218667_bib87","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-025-03279-w","article-title":"Targeting RNA splicing modulation: new perspectives for anticancer strategy?","volume":"44","author":"Lv","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218667_bib88","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ctrv.2015.04.003","article-title":"The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: a review of clinical studies","volume":"43","author":"Duvic","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218667_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104695","article-title":"Efficacy and safety of targeted therapy and immunotherapy in advanced vulvar squamous cell carcinoma: a scoping review","volume":"210","author":"Arenhardt","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2026.218667_bib90","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.2008.19.0694","article-title":"Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study","volume":"27","author":"Galanis","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1634\/theoncologist.2017-0501","article-title":"Phase II study of bevacizumab and vorinostat for patients with recurrent World Health Organization grade 4 malignant glioma","volume":"23","author":"Ghiaseddin","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2026.218667_bib92","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1080\/15548627.2020.1816343","article-title":"Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial","volume":"17","author":"Compter","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218667_bib93","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.3171\/foc.2003.14.2.4","article-title":"Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine","volume":"14","author":"Briceno","year":"2003","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.canlet.2026.218667_bib94","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2014.9.FOCUS14504","article-title":"Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy","volume":"37","author":"Golden","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.canlet.2026.218667_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116240","article-title":"Pp1-87B\/PPP1CC-JNK axis integrates apoptosis and ferroptosis-like cell death to regulate cell competition and tumorigenesis","volume":"44","author":"Kong","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218667_bib96","doi-asserted-by":"crossref","first-page":"27140","DOI":"10.1021\/acsami.5b07557","article-title":"Bioinert anodic Alumina nanotubes for targeting of endoplasmic reticulum stress and autophagic signaling: a combinatorial nanotube-based drug delivery system for enhancing cancer therapy","volume":"7","author":"Wang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.canlet.2026.218667_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116688","article-title":"Autophagy modulation in cancer therapy: challenges coexist with opportunities","volume":"276","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218667_bib98","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"Kelly","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218667_bib99","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/auto.29231","article-title":"Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors","volume":"10","author":"Mahalingam","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218667_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-19717-w","article-title":"Adverse drug reaction profiles of histone deacetylase inhibitors","volume":"15","author":"Begum","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218667_bib101","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1346-8138.2012.01554.x","article-title":"Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"39","author":"Wada","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.canlet.2026.218667_bib102","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clml.2017.05.003","article-title":"New agents in multiple myeloma: an examination of safety profiles","volume":"17","author":"Bringhen","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.canlet.2026.218667_bib103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218667_bib104","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-728-1","article-title":"Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF\/CELSR2\/p65\/Kla-HDAC1\/EPAS1 axis","author":"Gao","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.canlet.2026.218667_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101329","article-title":"Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma","volume":"84","author":"Gao","year":"2026","journal-title":"Drug Resist. Updates"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:19:40Z","timestamp":1785889180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":105,"alternative-id":["S0304383526004301"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218667","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218667"}}